Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroto Inaba

Showing results (171-180 of 214) with videos related to

Pageof 22
Sort By:
The Lancet. Oncology|July 25, 2017
Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group studyBenjamin O Wolthers, Thomas L Frandsen, André Baruchel, et al.
Nature Medicine|January 5, 2023
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment responseShawn H R Lee, Wenjian Yang, Yoshihiro Gocho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Improved prognosis for older adolescents with acute lymphoblastic leukemiaChing-Hon Pui, Deqing Pei, Dario Campana, et al.
Blood Cancer Discovery|July 12, 2021
Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapySima Jeha, John Choi, Kathryn G Roberts, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architecturesKelly R Barnett, Robert J Mobley, Jonathan D Diedrich, et al.
Research Square|November 28, 2024
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemiaCharles Mullighan, Ruth Wangondu, Emily Ashcraft, et al.
Leukemia|October 30, 2022
Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working GroupKentaro Ohki, Ellie R Butler, Nobutaka Kiyokawa, et al.
Cancer Cell|April 9, 2024
Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemiaXin Huang, Yizhen Li, Jingliao Zhang, et al.
Cancer|October 30, 2019
Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task ForceEtan Orgel, Thomas B Alexander, Brent L Wood, et al.
Blood|November 4, 2015
Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levelsCharles G Mullighan, Sima Jeha, Deqing Pei, et al.
Pageof 22

Showing results (171-180 of 214) with videos related to

Sort By:
Pageof 22
The Lancet. Oncology|July 25, 2017
Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group studyBenjamin O Wolthers, Thomas L Frandsen, André Baruchel, et al.
Nature Medicine|January 5, 2023
Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment responseShawn H R Lee, Wenjian Yang, Yoshihiro Gocho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Improved prognosis for older adolescents with acute lymphoblastic leukemiaChing-Hon Pui, Deqing Pei, Dario Campana, et al.
Blood Cancer Discovery|July 12, 2021
Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapySima Jeha, John Choi, Kathryn G Roberts, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Epigenomic mapping in B-cell acute lymphoblastic leukemia identifies transcriptional regulators and noncoding variants promoting distinct chromatin architecturesKelly R Barnett, Robert J Mobley, Jonathan D Diedrich, et al.
Research Square|November 28, 2024
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemiaCharles Mullighan, Ruth Wangondu, Emily Ashcraft, et al.
Leukemia|October 30, 2022
Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working GroupKentaro Ohki, Ellie R Butler, Nobutaka Kiyokawa, et al.
Cancer Cell|April 9, 2024
Single-cell systems pharmacology identifies development-driven drug response and combination therapy in B cell acute lymphoblastic leukemiaXin Huang, Yizhen Li, Jingliao Zhang, et al.
Cancer|October 30, 2019
Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task ForceEtan Orgel, Thomas B Alexander, Brent L Wood, et al.
Blood|November 4, 2015
Outcome of children with hypodiploid ALL treated with risk-directed therapy based on MRD levelsCharles G Mullighan, Sima Jeha, Deqing Pei, et al.
Pageof 22